Kawasaki Disease (cont.)
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
Catherine Burt Driver, MD
Catherine Burt Driver, MD, is board certified in internal medicine and rheumatology by the American Board of Internal Medicine. Dr. Driver is a member of the American College of Rheumatology. She currently is in active practice in the field of rheumatology in Mission Viejo, Calif., where she is a partner in Mission Internal Medical Group.
In this Article
- Kawasaki's disease facts
- What is Kawasaki's disease, and how is it diagnosed?
- What is mucocutaneous lymph node syndrome?
- What are the usual symptoms and signs of Kawasaki's disease?
- What are the less common findings?
- What is the difference between Kawasaki's disease and Kawasaki's syndrome?
- What causes Kawasaki's disease?
- Who develops Kawasaki's disease?
- How can Kawasaki's disease cause serious complications?
- What is the treatment for Kawasaki's disease?
- What is the prognosis for children with Kawasaki's disease?
- Can Kawasaki's disease be prevented?
- Find a local Pediatrician in your town
What is the prognosis for children with Kawasaki's disease?
Kawasaki's disease generally resolves on its own after four to eight weeks and with early treatment full recovery is usual.
However, the outcome is not so favorable in every case. Rarely, Kawasaki's disease can cause death from blood clots forming in abnormal areas of widening (aneurysms) of the heart arteries (coronary arteries). Those children with larger aneurysms have a worse prognosis because of this risk.
The earlier the diagnosis is made and treatment is begun the better the outcome.
Researchers are searching for methods of detecting which children are at risk for the development of aneurysms of the coronary arteries. Further research is under way to investigate a variety of criteria for atypical variants of Kawasaki's disease that do not have classical presentations.
Can Kawasaki's disease be prevented?
Because the cause of Kawasaki's disease has not been determined, there are no measures known that can prevent the disease.
Medically reviewed by Margaret Walsh, MD; American Board of Pediatrics
American College of Rheumatology National Meeting, Boston, 2007.
Klippel, J.H., et al. Primer on the Rheumatic Diseases. New York: Springer, 2008.
Ruddy, Shaun, et al., eds. Kelley's Textbook of Rheumatology. Philadelphia: W.B. Saunders Co., 2000.
Get the latest treatment options